Salmeterol was not as effective as triamcinolone for persistent asthma
- Once A Day Asthma Treatment. // Pediatrics for Parents;1999, Vol. 18 Issue 5, p7
Discusses the use of the corticosteroid inhaler Pulmicort in the control of mild to moderate asthma.
- Literature Reviews: Allergy and Immunology. Lampe, John B.; Melton Jr, A. L. // Clinical Pediatrics;Jan2000, Vol. 39 Issue 1, p62
Presents the summary of the article `Oral vs. IV Corticosteroids in Children Hospitalized With Asthma,' by J.M. Becker, A. Arora, R.J. Scarfone, N.D. Spector, et al., published in a 1999 issue of `Journal of Allergy and Clinical Immunology.'
- A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Chipps, Bradley E.; Chipps, Donna R. // Clinical Pediatrics;Apr2001, Vol. 40 Issue 4, p185
Summary: Systemic corticosteroids (CSs) are generally accepted as treatment for acute exacerbations of asthma. In contrast, inhaled corticosteroids (ICs) have been used for the long-term management of asthma but are not widely accepted for the treatment of asthma exacerbations. The onset of...
- What is the optimal dose of inhaled corticosteroids in adult asthma? Chapman, Kenneth R. // Patient Care;2/1/1997, Vol. 31 Issue 2, p24
Focuses on the use of prescribe inhaled corticosteroids in higher doses to manage adult asthma. What is the optimal dose of inhaled corticosteroids in asthma; Explanations to be considered if patients with asthma do not respond well to dosages of inhaled corticosteroid under 1,000 a day; Why...
- Comparison of the Asthma in America and Asthma Insight and Management surveys: Did asthma burden and care improve in the United States between 1998 and 2009? Nathan, Robert A.; Meltzer, Eli O.; Blaiss, Michael S.; Murphy, Kevin R.; Doherty, Dennis E.; Stoloff, Stuart W. // Allergy & Asthma Proceedings;Jan/Feb2012, Vol. 33 Issue 1, p65
Significant changes in asthma treatment guidelines and therapies occurred between the period of time in which the Asthma in America (AIA) and Asthma Insight and Management (AIM) surveys were conducted: 1998 and 2009, respectively. This study compares asthma burden and management in 1998 and...
- Review: Adding antileukotrienes to inhaled corticosteroids reduces exacerbations in symptomatic chronic asthma. Rees, P. John // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p99
Comments on a study which investigated the addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Results; Treatment which reduces the rate of exacerbations that require systemic corticosteroids; Effects of inhaled corticosteroids on asthma.
- What are the Alternatives to Increasing Inhaled Corticosteroids for the Long Term Control of Asthma? Flood-Page, P.; Barnes, N.C. // BioDrugs;2001, Vol. 15 Issue 3, p185
The Global Initiative for Asthma (GINA) guidelines stated the therapeutic goals for the management of asthma and, through a stepwise approach to treatment, defined the various grades of asthma severity and the therapeutic options available to the clinician at each step. This article considers...
- Smoking has a negative impact on asthma and alters the response to some asthma therapies. Adis International Limited // Drugs & Therapy Perspectives;Feb2006, Vol. 22 Issue 2, p23
Although many asthmatics are regular smokers, there are limited data on the response of smokers to asthma therapy. The symptoms of asthma are worse in smokers than in nonsmokers, with an increase in the frequency and severity of attacks. Corticosteroids are the most effective medication for the...
- The safety profile of ciclesonide in the treatment of persistent asthma. Craig, Timothy // Allergy & Asthma Proceedings;May/Jun2009, Vol. 30 Issue 3, p315
Inhaled corticosteroids (ICSs) are considered the most effective therapy currently available for persistent asthma and is the guideline-recommended first-line treatment for all patients requiring controller medication; however, the potential for oropharyngeal and systemic adverse events can be a...